
On Demand Replay: 8th Annual Diabetes, Obesity, & Metabolic Disease Conference
![]() Hurry! Offer expires June 30, 2023 at 11:59 pm ET!
|
|
Course Content
On Demand Replay: MONDAY, May 1, 2023
DAY 1 – Diabetes and Cardio-Renal Disease Disease Management with Cases |
|
M. McDonnell, MD | Contrasting the GLP-1 and Dual Incretin Receptor Agonists with SGLT2 Inhibitors in the Early Treatment of Diabetes |
G. Bakris, MD | Novel Medications for Resistant Hypertension: What the Future Holds |
M. McDonnell, MD | Selecting Therapies in the Older Outpatient with Diabetes: A Cardiometabolic Approach |
G. Bakris, MD | "Pillars of Therapy”: The 21st Century Approach to Halting Nephropathy from Diabetes |
M. McDonnell, MD & G. Bakris, MD | Cases in Diabetes, Kidney, and Cardio-Renal Disease |
On Demand Replay: TUESDAY, May 2, 2023
DAY 2 – Comprehensive Obesity Management and NAFLD/NASH with Case Studies |
|
D. Ryan, MD | Basics of Obesity Biology and Weight Loss Physiology |
R. Kushner, MD | Patient Assessment and Engagement |
R. Kushner, MD | Prescribing for Weight Management |
D. Ryan, MD | Future Lifestyle and Pharmacologic Directions in the Care of the Overweight Patient |
R. Kushner, MD & D. Ryan, MD | Cases in Obesity Management |
L. VanWagner, MD | Updates in NAFLD and NASH: A Primer for the PCP |
L. VanWagner, MD | Case Studies in NAFLD |
On Demand Replay: WEDNESDAY, May 3, 2023
DAY 3 – Hypertension and Dyslipidemia Management with Case Studies |
|
J. Basile, MD | Questions on Evaluating and Treating Hypertension in the Outpatient |
P. Jones, MD | Recommendations for Optimal LDL Treatment to Prevent ASCVD: Who to Treat and What Therapies to Use |
P. Jones, MD | What the Clinician Needs to Know About Triglycerides and HDL Cholesterol |
J. Basile, MD & P. Jones, MD | Cases on Dyslipidemia and Hypertension |
Program Overview
This CME activity is comprised of recordings from the 8th Annual Diabetes, Obesity, and Metabolic Disease Conference that took place in New Orleans, LA on May 1-3, 2023. This CME is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. The CME conference will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice.
Cardiometabolic disorders are a cluster of health conditions associated with cardiovascular disease and type 2 diabetes. It is estimated that over 1/3 of American’s suffer from a cardiometabolic disorder. The associated morbidity and mortality deserve increased clinical attention as we address risk factors predisposing individuals to these disorders. This program will help identify these conditions and their related complications to enable clinicians to appropriately intervene with evidence-based treatments and risk-factor control while improving patient education. The format of this course is streaming-only (video recordings are not downloadable).
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
- Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
- Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
George Bakris, MD, MA, FASH, FASN, FAHA
Professor of Medicine
Director, ASH Comprehensive Hypertension Center
The University of Chicago Medicine
Chicago, IL
Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Division of Cardiology
Medical University of South Carolina
Ralph H Johnson VA Medical Center
Previous Vice-Chair of Clinical Programs AHA Council of Hypertension
US National Leader SURPASS-CVOT
Charleston, SC
Peter Howard Jones, MD, FACP, FNLA
Associate Professor of Emeritus
Baylor College of Medicine
Houston, TX
Robert F. Kushner, MD, MS
Professor of Medicine
Northwestern University Feinberg School of Medicine
Director, Center of Lifestyle Medicine
Chicago, IL
Marie E. McDonnell, MD
Chief, Diabetes Section
Division of Endocrinology, Diabetes and Hypertension
Associate Professor of Medicine, Harvard Medical School
Brigham and Women's Hospital
Arlington, MA
Donna H. Ryan, MD, FACP
Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, LA
Lisa VanWagner, MD, MSc, FAST, FAHA
Associate Professor of Medicine
Director of Clinical Research
Division of Digestive and Liver Diseases
University of Texas Southwestern Medical Center
Dallas, TX
Accreditation
American Academy of Family Physicians: The AAFP has reviewed the On Demand Replay: 8th Annual Diabetes, Obesity, and Metabolic Disease Conference (Enduring) and deemed it acceptable for up to 15 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 5/12/2023 to 5/1/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15 hours of participation, 11 of which can be used towards Pharmacology, for completing this activity.
Release Date: 5/12/2023
Expiration Date: 5/1/2024 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that they have no relevant financial relationships with a ineligible company that may impact upon this CME activity:
- Raymond E. Major, MD – Reviewer
- Walter Ejnes, CHCP – Reviewer & Planning Committee (Continuing Education Company)
- Lizzie Masters – Reviewer (Continuing Education Company)
- Beth Ryan Townsend, CHCP – Reviewer (Continuing Education Company)
- Su Barnwell – Planner (Continuing Education Company)
Faculty Disclosures:
The following individuals were responsible for developing their own content, which has been reviewed by Continuing Education Company’s Medical Education Advisory Committee to ensure it is unbiased. Additionally, all individuals have indicated that if they had a financial relationship(s) with an ineligible company over the past 24 months, this relationship has been mitigated and does not have an impact upon this CME activity. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Faculty | Disclosures |
George Bakris, MD | Advisory Board, Consultant/Executive Committee of Clinical Trials: Ionis |
Consultant/Executive Committee of Clinical Trials: Alnylam; Astra Zeneca; Bayer; InREGEN; Janssen; KBP Biosciences; Novo Nordisk | |
Editor: AM J Nephrology | |
Employment: University of Chicago Medicine, supported by T32 NIH grant DK07011 | |
Jan Basile, MD | Consultant: Eli Lilly (SURPASS-CVOT); UpToDate (Hypertension Section) |
Research Grant: Ablative Solutions (Target BP 1); ReCor (RADIANCE I and II) | |
Peter H Jones, MD | Consultant: Esperion |
Robert Kushner, MD | Advisory Board: Novo Nordisk; Weight Watchers |
Consultant: Altimmune; Boehringer Ingelheim; Lilly; Pfizer | |
Marie McDonnell, MD | Nothing to Disclose |
Donna Ryan, MD | Advisory Board: Altimmune; Amgen; Biohaven; Boehringer Ingelheim; Calibrate; Carmot; Epitomee Medical; Gila Therapeutics; Novo Nordisk; Real Appeal; Structure Therapeutics; Wondr Health; Zealand Pharma |
Chair Steering Committee SELECT Trial: Novo Nordisk | |
Consultant: Calibrate; Eli Lilly; Epitomee Medical; IFA Celtic; Scientific Intake; Xeno Biosciences | |
Ownership Interest: Calibrate; Epitomee Medical | |
Shareholder: Xeno Biosciences | |
Speakers Bureau: Novo Nordisk | |
Stockholder: Scientific Intake | |
Lisa VanWagner, MD | Consultant: Novo Nordisk; Numares |
Research Grant: Entanta; NGM Pharmaceuticals |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later

30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.